• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY ICL (IMPLANTABLE COLLAMER LENS); INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY ICL (IMPLANTABLE COLLAMER LENS); INTRAOCULAR LENS Back to Search Results
Model Number MICL12.6
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Cataract, Induced (1767); Loss of Vision (2139)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Lens implanted.
 
Event Description
The patient reported the surgeon implanted a 12.6mm micl12.6 implantable collamer lens, -8.5 diopter, in his left eye (os).The patient reported his vision has changed to -0.5.The facility reported the patient has an early cataract, due to the aging process and not related to the device.The lens remains implanted.The patient's post-op va was 20/25.
 
Manufacturer Narrative
Method: medical review, work order search results: per medical review: on (b)(6) 2015 the patient completed 36 month post-treatment patient follow-up form and reported decrease of visual acuity following icl implantation.According to dcr form, received on 11/19/15, the cause of the event was a cataract development due to aging process and not related to the device.Icl remained implanted and ucva was 20/25 with good prognosis.Seriousness is based on no reported loss of bcva and no report of any secondary intervention planned or scheduled.It should be noted that at the time of the icl implantation patient was (b)(6) and per dfu indications: "the visian icl is indicated for use in adults 21-45 years of age", therefore there is no sufficient safety and effectiveness data to support implantation in such patients.Furthermore, literature reports that only 1-2% of patients develop clinically significant cataract following icl implantation probably due to patient related factors (especially high myopes and older patients).A work order search found no similar complaints.Claim #(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ICL (IMPLANTABLE COLLAMER LENS)
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
haupstrasse 104
nidau, CH-25 60
SZ  CH-2560
Manufacturer (Section G)
STAAR SURGICAL COMPANY
haupstrasse 104
nidau, CH-25 60
SZ   CH-2560
Manufacturer Contact
althea watson
1911 walker avenue
monrovia, CA 91016
6263037902
MDR Report Key5328083
MDR Text Key34379782
Report Number2023826-2015-01750
Device Sequence Number1
Product Code MTA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,study
Reporter Occupation Patient
Type of Report Initial,Followup,Followup
Report Date 09/08/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date01/31/2014
Device Model NumberMICL12.6
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 09/08/2015
Initial Date FDA Received12/24/2015
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received03/16/2016
09/14/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/22/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age52 YR
-
-